Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model-Reference-Cited by-同舟云学术

Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model

Published:2015-12-29 Issue:4 Volume:113 Page:438-442
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Bespalov Vladimir G.¹²,Kireeva Galina S.¹²,Belyaeva Olesya A.¹²,Kalinin Oleksiy E.³,Senchik Konstantin Y.¹,Stukov Alexandr N.¹,Gafton Georgy I.¹,Guseynov Konstantin D.¹,Belyaev Alexey M.¹

Affiliation:

1. Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia

2. ITMO University; 49, Kronverksky Avenue; Saint-Petersburg Russia

3. Lugansk Oncological Dispensary, Lugansk, Ukraine; 8, Krasnodonskaya Street; Lugansk Ukraine

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.24140/fullpdf

Reference30 articles.

1. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N Engl J Med,2006

2. Randomized phase III study of intravenous (IV) paclitaxel and cisplatin versus IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): A gynecologic oncology group trial (GOG 172);Armstrong;Proc Am Soc Clin Oncol,2002

3. Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest oncology group study S0009;Tiersten;Gynecol Oncol,2009

4. Results of the 2006 innsbruck international consensus conference on intraperitoneal chemotherapy in patients with ovarian cancer;Marth;Cancer,2007

5. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitonealchemotherapy in optimal stage III ovarian and primary peritoneal cancer: A gynecologic oncology group study;Walker;Gynecol Oncol,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-covalent conjugate based on graphene oxide and a cytotoxic agent containing 1,3,5-triazine derivative and (5-phenyl-2H-tetrazol-2-yl)acetoxy moiety: Synthesis, characterization, properties and cytotoxic activity;Mendeleev Communications;2023-11

2. Nanomedicines Bearing an Alkylating Cytostatic Drug from the Group of 1,3,5-Triazine Derivatives: Development and Characterization;Pharmaceutics;2022-11-18

3. Assessment of antitumor activity of BP-C1, a platinum-based anticancer agent with a lignin-derived polymeric ligand, in autochthonous induced and spontaneous carcinogenesis rodent models;Journal of Trace Elements in Medicine and Biology;2022-09

4. A cytostatic drug from the class of triazine derivatives: Its properties in aqueous solutions, cytotoxicity, and therapeutic activity;Journal of Molecular Liquids;2022-06

5. Biocompatibility and bioactivity study of a cytostatic drug belonging to the group of alkylating agents of the triazine derivative class;Journal of Molecular Liquids;2021-12